Xingnaojing Injection Protects against Cerebral Ischemia Reperfusion Injury via PI3K/Akt-Mediated eNOS Phosphorylation

Evidence-based Complementary and Alternative Medicine : ECAM
Yue-Ming ZhangSi-Xi Zhang

Abstract

Xingnaojing (XNJ) injection, derived from traditional Chinese medicine formulation, has a protective effect against stroke, but the underlying mechanism is unclear, which severely limited its clinical application. This research aims to elucidate the role and mechanism of XNJ in reducing cerebral ischemic reperfusion (I/R) injury. Rats received 2 h cerebral ischemia followed by reperfusion of 24 h and were intraperitoneally given 5, 10, or 15 ml/kg XNJ 24 h before ischemia and at the onset of reperfusion, respectively. TTC staining, HE staining, and neurological score were implied to evaluate the effectiveness of XNJ. The protein expressions of PI3K/Akt and eNOS signaling were measured. Experiments were further performed in human brain microvascular endothelial cells (HBMECs) to investigate the protective mechanisms of XNJ. HBMECs were subjected to 3 h oxygen and glucose deprivation following 24 h of reoxygenation (OGD) to mimic cerebral I/R in vitro. PI3K inhibitor LY294002 was added with or without the preconditioning of XNJ. Multiple methods including western blot, immunofluorescence, DAPI staining, JC-1, and flow cytometry were carried out to evaluate the effect of XNJ on HBMECs. XNJ could improve rat cerebral ischemic injur...Continue Reading

References

Mar 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·P M BathJ F Martin
Jan 1, 1989·Stroke; a Journal of Cerebral Circulation·E Z LongaR Cummins
Jul 8, 2000·Neuropathology and Applied Neurobiology·B S AspeyM J Harrison
Nov 4, 2000·The Journal of Cell Biology·H ZhouR N Pittman
Aug 22, 2006·Cancer Biology & Therapy·Kageaki KuribayashiWafik S El-Deiry
Jun 9, 2007·The Journal of Clinical Investigation·Dmitriy N AtochinPaul L Huang
Mar 19, 2009·Pharmacological Reviews·Noboru TodaTomio Okamura
Sep 4, 2010·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Hisae YoshitomiYukio Yamori
May 17, 2011·Lancet·Peter LanghorneGert Kwakkel
Jun 5, 2013·Cold Spring Harbor Perspectives in Biology·Amanda B ParrishSally Kornbluth
Oct 10, 2013·Ageing Research Reviews·David Yang-Wei FannThiruma V Arumugam
Mar 27, 2015·CNS Neuroscience & Therapeutics·Jun ChenGuo-Yuan Yang
Jun 21, 2016·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Haijie YuYingxian Sun
Dec 26, 2016·Neurochemistry International·Wijitra ChumboatongJiraporn Tocharus
Jun 5, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Hong-Hui YangJian-Min Yao
Mar 7, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yong LiangXiao-Juan Li
Mar 27, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Guoping WangYuyou Zhu

❮ Previous
Next ❯

Methods Mentioned

BETA
protein concentration
Assay

Software Mentioned

Image J

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.